454 related articles for article (PubMed ID: 24414799)
1. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
Zhang HS; Chen XY; Wu TC; Zhang FJ
J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
Zhang HS; Sang WW; Wang YO; Liu W
J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
[TBL] [Abstract][Full Text] [Related]
4. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
Zhang HS; Ruan Z; Sang WW
J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
[TBL] [Abstract][Full Text] [Related]
5. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
Zhang HS; Wu TC; Sang WW; Ruan Z
Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
Zhang HS; Wu MR
Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
[TBL] [Abstract][Full Text] [Related]
9. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Zhang HS; Sang WW; Ruan Z; Wang YO
Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
[TBL] [Abstract][Full Text] [Related]
10. MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1.
Zhang HS; Wu TC; Sang WW; Ruan Z
Biochim Biophys Acta; 2012 May; 1823(5):1017-23. PubMed ID: 22406815
[TBL] [Abstract][Full Text] [Related]
11. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.
Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z
FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
13. EZH2 phosphorylation regulates Tat-induced HIV-1 transactivation via ROS/Akt signaling pathway.
Zhang HS; Liu Y; Wu TC; Du GY; Zhang FJ
FEBS Lett; 2015 Dec; 589(24 Pt B):4106-11. PubMed ID: 26632198
[TBL] [Abstract][Full Text] [Related]
14. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
Chande AG; Baba M; Mukhopadhyaya R
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of SIRT1 by HIV-1 viral protein Tat results in activation of p53 pathway.
Thakur BK; Chandra A; Dittrich T; Welte K; Chandra P
Biochem Biophys Res Commun; 2012 Jul; 424(2):245-50. PubMed ID: 22732402
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells.
Zhang HS; Wang SQ
Biochem Pharmacol; 2007 May; 73(9):1358-66. PubMed ID: 17303087
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
Endo-Munoz L; Warby T; Harrich D; McMillan NA
Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the SIRT1-AMPK signaling pathway.
Yu JW; Sun LJ; Liu W; Zhao YH; Kang P; Yan BZ
Int J Infect Dis; 2013 Jul; 17(7):e539-45. PubMed ID: 23510538
[TBL] [Abstract][Full Text] [Related]
19. PKM2-mediated inhibition of autophagy facilitates Tat's inducing HIV-1 transactivation.
Zhang HS; Zhang ZG; Zhou Z; Du GY; Li H; Yu XY; Huang YH
Arch Biochem Biophys; 2017 Jul; 625-626():17-23. PubMed ID: 28583828
[TBL] [Abstract][Full Text] [Related]
20. NAMPT/SIRT1 Attenuate Ang II-Induced Vascular Remodeling and Vulnerability to Hypertension by Inhibiting the ROS/MAPK Pathway.
Zhou L; Zhang S; Bolor-Erdene E; Wang L; Tian D; Mei Y
Oxid Med Cell Longev; 2020; 2020():1974265. PubMed ID: 33488923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
